Follow-on Biologics Base Camp: Senate Has Four Rival Proposals
This article was originally published in The Pink Sheet Daily
Executive Summary
Brand biologics fare well in the amendments prepared for the HELP Committee mark-up, as even Sen. Brown offers at least seven years of exclusivity.
You may also be interested in...
Follow-on Biologics: As Mark-Ups Loom, What's Waxman's End Game?
Coming to an abrupt halt after racing at full speed is never easy, but that seems to be the best play available to generic advocates of a legislative pathway for follow-on biologics
Follow-on Biologics: As Mark-Ups Loom, What's Waxman's End Game?
Coming to an abrupt halt after racing at full speed is never easy, but that seems to be the best play available to generic advocates of a legislative pathway for follow-on biologics
Follow-on Biologics Vote Time: Eshoo Plans Challenge Of Waxman At House Mark-up
With so many Democratic sponsors, Eshoo appears to need to pick up only nine of the 11 undeclared Republicans in order to pass her brand-friendly legislation.